交易中 03-25 10:51:26 美东时间
+3.180
+2.77%
今日重点评级关注:Guggenheim:维持Cabaletta Bio"买入"评级,目标价从15美元升至16美元;HC Wainwright & Co.:维持Palvella Therapeutics"买入"评级,目标价从255美元升至270美元
今天 10:31
BofA Securities initiates coverage on Nebius with a Buy rating and $150 price target, citing rapid growth in AI Infrastructure-as-a-Service and scalable GPU offerings.
今天 01:07
Market Overview Indices were down again last week but in many ways, they masked...
03-24 22:54
原油期货再起升势,美油期货涨近5%;油气股集体走高,西方石油、埃克森美孚涨超2%;云计算概念股CoreWeave、Nebius涨超1.5%>>
03-24 21:43
B of A Securities analyst Tal Liani initiates coverage on Nebius Group (NASDAQ:NBIS) with a Buy rating and announces Price Target of $150.
03-24 20:39
CCL shares jump 3.5% as Trump pauses Iran energy strikes, sending oil prices down 10%. See how falling fuel costs are boosting cruise stocks.
03-23 20:23
Nebius closed a convertible notes offering worth over $4 billion, with proceeds aimed at AI cloud expansion and data center investments.
03-23 18:55
Nebius Group (NBIS) seeks $3.75B in debt funding to fuel AI growth following major deals with Meta and Nvidia. Get the full investor update.
03-17 21:19
https://nebius.com/newsroom/nebius-group-announces-proposed-private-offering-of-3-75-billion-of-convertible-senior-notes
03-17 19:59